Like in our previous investigations, regional [18F]PI-2620 tau-PET signals as well as condensed tau-PET components resulting from the PCA did not correlate with symptom severity measured by the PSP rating scale. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.